Drugs & Medications
By KAVAPOINT
Drugs & Medications is a professional-grade medical reference utility for iOS that provides offline access to drug descriptions, usage, and contraindications.
The App DNA
What makes this app unique?
It removes the friction of connectivity requirements in clinical environments, serving as a reliable backup for physicians and pharmacists when network access is unavailable.
For Healthcare professionals including pharmacists, nurses, and physicians, as well as medical students.
What does it look like?
Key features
Access to drug descriptions, usage, and contraindications without an internet connection.
Visual identification tool for medications requiring internet access.
Integrated feed for the latest FDA press releases and safety updates.
How much does it cost?
The $0.99 paid model provides full database access without recurring fees, which appeals to users avoiding subscription fatigue.
Velocity
Dormant developmentShow more...
5 versions in history. Development pace: zombie.
Who built it?
KAVAPOINT
3 apps tracked · Medical
![Flashlight Pro [Multipurpose LED light]](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/d7/bf/ae/d7bfaed5-3dfd-0bec-f088-983650770efa/pr_source.png/512x512bb.jpg)
Flashlight Pro [Multipurpose LED light]
ICU Pearls Critical Care tipsUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Drugs & Medications
How's the Medical market?
Drugs & Medications occupies a legacy niche in the Medical category, relying on its offline-first database to maintain a 4.0-star rating despite a lack of updates since 2017.
Read the market outlookThe rivals identified
By Ray Flinkerbusch
Both apps target medication management, but they serve distinct use cases: Drugs & Medications provides clinical reference data for professionals, while My Next Med focuses on family-level adherence and dosing schedules.
- My Next Med enables multi-user family profiles; Drugs & Medications lacks patient-specific tracking features.
- My Next Med provides interval-based dosing calculations; Drugs & Medications focuses on static drug reference data.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Drugs & Medications
Where is it heading?
Users report: The medical reference market is consolidating around tools that offer active clinical decision support and EMR integration. Drugs & Medications remains exposed due to its static database, and the lack of updates will likely lead to a gradual decline in user relevance as professional standards evolve.
- The absence of feature updates for over 3,000 days signals a transition to maintenance-only status, which reduces the app's relevance against competitors.
The SWOT
- Offline-first architecture ensures reliability in remote clinical environments
- Localized database expansion for underserved international medical markets
Next best moves
Sunset the app to focus resources on new clinical utilities because the development cycle has been dormant for eight years → prevent brand drag
The counter-intuitive read
The app's lack of updates is its primary retention lever…
Read the full takeFeature gaps
Integrated clinical decision support (available in MDCalc but absent here) +1
Since the last report: The app's positioning shifted from a generic medical reference tool to a specialized offline-first utility, accompanied by formal documentation of its $0.99 pricing and a transition to maintenance-only status.
Bottom line
Drugs & Medications relies on its offline-first database to retain a professional user base, but the lack of feature investment since 2017 limits its ability to compete with modern clinical decision support tools.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated